Doxorubicin Thermosensitive Liposomal(Thermosome)

N/A

Report date: 2024/02/22 16:15:21

Base Information

Drug NameDoxorubicin Thermosensitive Liposomal(Thermosome)
Drug Alias NameTHE001THE-001
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionDNA intercalatorsTopoisomerase II inhibitors
TargetsTopoisomerase IIDNA
Therapy Area/IndicationsUrinary Bladder NeoplasmsBreast NeoplasmsSarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesThermosome GmbH
China Registration ClassN/A

Develop Information

Active CompaniesThermosome GmbH
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsBreast NeoplasmsSarcoma
Inactive IndicationsN/A

Other Information

ATC CodeL01DB01
Related LinksN/A